Literature DB >> 23665573

An evaluation of the activity of a 7-day, nurse-led specialist palliative care service in an acute district general hospital.

Sally Hall1, Andrew Davies.   

Abstract

INTRODUCTION: This report describes the activity of a new 7-day-per-week, nurse-led palliative care service in an acute district general hospital in the UK.
METHODS: The service is based in a hospital with an integral cancer centre. On the weekends, one clinical nurse specialist (CNS) is present within the hospital, with a consultant providing telephone support. The data for this report was obtained by reviewing the team's clinical database and the patients' individual clinical assessments.
RESULTS: During the first year, the CNSs undertook 651 face-to-face weekend consultations. Overall, 25% of the total consultations and 18% of new patient consultations were undertaken on the weekends. The primary reasons for reviewing patients on the weekends were pain (46%), other symptoms (27.5%), and patient on the Liverpool Care Pathway (17%). Overall, 23% of new patients died over the weekend or in the early hours of the Monday morning.
CONCLUSIONS: This service evaluation provides evidence of the value of having a 7-day-per-week palliative care service in an acute district general hospital.

Entities:  

Mesh:

Year:  2013        PMID: 23665573     DOI: 10.12968/ijpn.2013.19.3.148

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  2 in total

1.  Telehealth in palliative care is being described but not evaluated: a systematic review.

Authors:  Sophie Hancock; Nancy Preston; Helen Jones; Amy Gadoud
Journal:  BMC Palliat Care       Date:  2019-12-13       Impact factor: 3.234

2.  Care provided and care setting transitions in the last three months of life of cancer patients: a nationwide monitoring study in four European countries.

Authors:  Winne Ko; Luc Deliens; Guido Miccinesi; Francesco Giusti; Sarah Moreels; Gé A Donker; Bregje Onwuteaka-Philipsen; Oscar Zurriaga; Aurora López-Maside; Lieve Van den Block
Journal:  BMC Cancer       Date:  2014-12-16       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.